Haijun Deng

7PUBLICATIONS
10CO-AUTHORS
Innate immunityCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersSurgery
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 07, 2026
Bifidobacterium animalis suppresses melanoma progression and activates anti-tumor immunity by inhibiting YAP1 expression in CD8+ T cells.

|Jul 02, 2025
Caffeine enhances antitumor T-cell activity by suppressing kynurenine pathway in colorectal cancer.

Yuechen Liu, Zhengyu Liu, Yating Hu

|Jun 01, 2024
DYNLL1 accelerates cell cycle via ILF2/CDK4 axis to promote hepatocellular carcinoma development and palbociclib sensitivity.

Yuechen Liu, Zhenkang Li, Jinchao Zhang

|Oct 20, 2023
Preservation versus resection of Denonvilliers' fascia in total mesorectal excision for male rectal cancer: follow-up analysis of the randomized PUF-01 trial.

Jiafeng Fang, Bo Wei, Zongheng Zheng

|Jun 30, 2021
S100P contributes to promoter demethylation and transcriptional activation of SLC2A5 to promote metastasis in colorectal cancer.

Mingdao Lin, Yuan Fang, Zhenkang Li

|Dec 27, 2019
SNX16 activates c-Myc signaling by inhibiting ubiquitin-mediated proteasomal degradation of eEF1A2 in colorectal cancer development.

Zhiyong Shen, Yongsheng Li, Yuan Fang

Pageof 2

Frequent Collaborators

3 joint publications

Zhiyong Shen

2 joint publications

Yongsheng Li

2 joint publications

Yuechen Liu

2 joint publications

Yizhi Zhan